Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
PRProPhase Labs, Inc. logo

ProPhase Labs, Inc. (PRPH)

Other OTC · Currency in USD
$0.01 ▲ +0.00 (+5.26%)
At close: Oct 23, 4:00 PM ET. Market closed.

Summary

Previous Close
$0.01
Open
$0.01
Day's Range
$0.01 – $0.01
52 Week Range
$0.01 – $4.20
Volume
6
Avg. Volume
253,967
Market Cap
$140.16K
Beta (5Y Monthly)
0.14
PE Ratio (TTM)
--
EPS (TTM)
-$1.62
Earnings Date
Nov 16, 2026
Forward Dividend & Yield
$12.00 (120,000.00%)
Ex-Dividend Date
May 24, 2022
1y Target Est
$140.00

Profile: ProPhase Labs, Inc.

Sector
Healthcare
Industry
Medical - Pharmaceuticals
Full-time employees
19
CEO
Ted William Karkus

ProPhase Labs, Inc., founded in 1989 in Garden City, New York (and previously known as The Quigley Corporation), operates as a diversified company with two main areas of focus: Consumer Products and Diagnostic Services. Through its Consumer Products division, ProPhase Labs is actively involved in the entire process—from researching and developing to manufacturing, distributing, marketing, and selling—a range of over-the-counter (OTC) healthcare items and nutritional supplements within the United States. Notable offerings include dietary supplements like Legendz XL, which supports male sexual health, and Triple Edge XL, formulated to enhance energy and stamina.

Earnings

Next report: Mon, Nov 16, 2026
EPS estimate $2.05 · Revenue est. $11.98M
DateEst.Actual
Aug 19, 2026–-$0.22
Jun 30, 2026-$1.20-$0.43Beat
Apr 14, 2026-$1.20-$0.87Beat
Nov 19, 2025-$1.10-$1.60Miss
Aug 13, 2025-$1.50-$1.10Beat
May 20, 2025-$1.80-$1.20Beat

Analyst view

Consensus price target
$140.00 ▲ +1,399,900.0%
Range $140.00 – $140.00
Rating: Buy
Buy 50% · Hold 50% · Sell 0%

Get free alerts on PRPH and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.